A Clinical Trial Evaluating the Safety and Efficacy of Myelin-peptide Loaded tolDC as Treatment for MS

Clinical trial NCT06715605 · WITHDRAWN

Trial details

NCT number: NCT06715605
Sponsor: University Hospital, Antwerp
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2025-04-30
Primary completion: 2025-04-30
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.